Literature DB >> 20421560

Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era.

Joshua P Metlay1, Ebbing Lautenbach, Yimei Li, Justine Shults, Paul H Edelstein.   

Abstract

BACKGROUND: The introduction of a pneumococcal conjugate vaccine has been associated with a shift in the serotypes responsible for bacteremic pneumococcal disease. We examined recent trends in serotypes responsible for disease and current risk factors among adults.
METHODS: Data were obtained from 48 acute care hospitals in the 5-county region surrounding Philadelphia, Pennsylvania, from October 1, 2002, through September 30, 2008, on all hospitalized adult patients with community-acquired bacteremic pneumococcal disease. Isolates were serotyped and patient characteristics were compared with data from a household survey of the adult population in the region.
RESULTS: During the study period, the annual rate of disease due to vaccine serotypes declined by 29% per year, but the rate of disease due to nonvaccine serotypes increased 13% per year, yielding an overall 7% increase in the annual rate of disease among adults. Advanced age was a risk factor for infection with nonvaccine serotypes compared with vaccine serotypes. Comparing all patients with the source population, African Americans were at increased risk of infection, and the presence of additional children in the home was associated with decreased risk of disease. Smoking, advanced age, and diabetes mellitus remained important risk factors in adults.
CONCLUSIONS: New serotypes are replacing the serotypes covered in the conjugate vaccine. While some risk factors for pneumococcal disease remain unchanged, the observation that exposure to children in the home is associated with lower risk of disease suggests that the changing epidemiology of pneumococcal disease may be altering the dominant modes of transmission in the community.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421560      PMCID: PMC2946166          DOI: 10.1001/archinternmed.2010.53

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  22 in total

1.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Authors:  K A Robinson; W Baughman; G Rothrock; N L Barrett; M Pass; C Lexau; B Damaske; K Stefonek; B Barnes; J Patterson; E R Zell; A Schuchat; C G Whitney
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

2.  Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.

Authors:  J P Nuorti; J C Butler; M M Farley; L H Harrison; A McGeer; M S Kolczak; R F Breiman
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

3.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10-06

4.  American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.

Authors: 
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

5.  Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

Authors:  Daniel R Feikin; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2002-08-07       Impact factor: 9.079

6.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

7.  Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.

Authors:  Brendan Flannery; Stephanie Schrag; Nancy M Bennett; Ruth Lynfield; Lee H Harrison; Arthur Reingold; Paul R Cieslak; James Hadler; Monica M Farley; Richard R Facklam; Elizabeth R Zell; Cynthia G Whitney
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

8.  Multinational study of pneumococcal serotypes causing acute otitis media in children.

Authors:  William P Hausdorff; Greg Yothers; Ron Dagan; Terhi Kilpi; Stephen I Pelton; Robert Cohen; Michael R Jacobs; Sheldon L Kaplan; Corinne Levy; Eduardo L Lopez; Edward O Mason; Vassiliki Syriopoulou; Brian Wynne; John Bryant
Journal:  Pediatr Infect Dis J       Date:  2002-11       Impact factor: 2.129

9.  Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes.

Authors:  Werner C Albrich; Dominique L Monnet; Stephan Harbarth
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

10.  Streptococcus pneumoniae serotype 19A in children, South Korea.

Authors:  Eun Hwa Choi; So Hee Kim; Byung Wook Eun; Sun Jung Kim; Nam Hee Kim; Jina Lee; Hoan Jong Lee
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more
  8 in total

1.  Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays.

Authors:  Richard G Wunderink; Wesley H Self; Evan J Anderson; Robert Balk; Sherene Fakhran; Daniel Mark Courtney; Chao Qi; Derek J Williams; Yuwei Zhu; Cynthia G Whitney; Matthew R Moore; Anna Bramley; Seema Jain; Kathryn M Edwards; Carlos G Grijalva
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

Review 2.  Paediatric pneumococcal disease in Central Europe.

Authors:  R Prymula; R Chlibek; I Ivaskeviciene; A Mangarov; Zs Mészner; P Perenovska; D Richter; N Salman; P Simurka; E Tamm; G Tešović; I Urbancikova; V Usonis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-11       Impact factor: 3.267

3.  Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era.

Authors:  Zhenying Liu; Irving Nachamkin; Paul H Edelstein; Ebbing Lautenbach; Joshua P Metlay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

4.  Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies.

Authors:  K A Feemster; Y Li; A R Localio; J Shults; P Edelstein; E Lautenbach; T Smith; J P Metlay
Journal:  Epidemiol Infect       Date:  2012-10-31       Impact factor: 2.451

5.  Validation of a Pediatric Primary Care Network in a US Metropolitan Region as a Community-Based Infectious Disease Surveillance System.

Authors:  Kristen A Feemster; Yimei Li; Robert Grundmeier; A Russell Localio; Joshua P Metlay
Journal:  Interdiscip Perspect Infect Dis       Date:  2011-12-07

6.  Epidemiology of pneumococcal disease in a national cohort of older adults.

Authors:  Haley J Morrill; Aisling R Caffrey; Eunsun Noh; Kerry L LaPlante
Journal:  Infect Dis Ther       Date:  2014-04-12

Review 7.  Second hand smoke exposure and the risk of invasive meningococcal disease in children: systematic review and meta-analysis.

Authors:  Rachael L Murray; John Britton; Jo Leonardi-Bee
Journal:  BMC Public Health       Date:  2012-12-10       Impact factor: 3.295

8.  Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands.

Authors:  S P Van Mens; A M M Van Deursen; S C A Meijvis; B J M Vlaminckx; E A M Sanders; H E De Melker; L M Schouls; A Van Der Ende; S C De Greeff; G T Rijkers
Journal:  Epidemiol Infect       Date:  2013-11-11       Impact factor: 4.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.